1-8 of 8
Vincent Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-B02: Detection of Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Free
Eric A. A. Severson, Gregory M. Riedlinger, Mendel Goldfinger, Caitlin Connelly, Shakti Ramkissoon, Garrett Frampton, Jeffrey Ross, Vincent Miller, Jo-Anne Vergilio, Julia Elvin, Mohammad Hadigol, Kim M. Hirshfield, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Hossein Khiabanian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): LB-B02.
https://doi.org/10.1158/1535-7163.TARG-17-LB-B02
Published: 01 January 2018
View article titled, Abstract LB-B02: Detection of Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing
Journal Articles

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Free
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P. Patel, Garrett M. Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (11): 2598–2608.
https://doi.org/10.1158/1535-7163.MCT-17-0386
Published: 01 November 2017
View article titled, Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Open the PDF for Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics

Free
Jennifer J. Wheler, Filip Janku, Aung Naing, Yali Li, Bettzy Stephen, Ralph Zinner, Vivek Subbiah, Siqing Fu, Daniel Karp, Gerald S. Falchook, Apostolia M. Tsimberidou, Sarina Piha-Paul, Roosevelt Anderson, Danxia Ke, Vincent Miller, Roman Yelensky, J. Jack Lee, David Hong, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (10): 2475–2485.
https://doi.org/10.1158/1535-7163.MCT-16-0196
Published: 02 October 2016
View article titled, TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
Open the PDF for TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics in another window
Includes: Supplementary data
Journal Articles

Abstract C90: Dependence of afatinib and cetuximab resistant lung adenocarcinomas on mTOR signaling.

Free
Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, Zenta Walter, Guoping Cai, Anna Wurtz, Zhongming Zhao, Elisa Elisa de Stanchina, Leora Horn, David Carbone, Philip J. Stevens, Vincent Miller, Scott Gettinger, William Pao, Katerina Politi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C90.
https://doi.org/10.1158/1535-7163.TARG-13-C90
Published: 01 November 2013
View article titled, Abstract C90: Dependence of afatinib and cetuximab resistant lung adenocarcinomas on mTOR signaling.
Journal Articles

A pilot phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.

Free
Eric Haura, Timothy Larson, Philip Stella, Lyudmila Bazhenova, Vincent Miller, Roger Cohen, Peter Eisenberg, Paulina Selaru, Keith Wilner, Alejandro Ricart, Sirish Gadgeel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B110.
Published: 01 November 2007
View article titled, A pilot phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.
Journal Articles

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Free
James Bean, Cameron Brennan, Jin-Yuan Shih, Gregory Riely, Agnes Viale, Lu Wang, Dhananjay Chitale, Noriko Motoi, Janos Szoke, Stephen Broderick, Marissa Balak, Wen-Cheng Chang, Chong-Jen Yu, Adi Gazdar, Harvey Pass, Valerie Rusch, William Gerald, Shiu-Feng Huang, Pan-Chyr Yang, Vincent Miller, Marc Ladanyi, Chih-Hsin Yang, William Pao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): PR-10.
Published: 01 November 2007
View article titled, MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Journal Articles

Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)

Free
Leonard James, Christopher Azzoli, Lee Krug, Vincent Miller, Priyam Tripathi, Sara Subzwari, Leslie Tyson, Megan Dunne, Martha Huntington, Michael Saunders, Mark Kris
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A143.
Published: 01 November 2007
View article titled, Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
Journal Articles

A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations

Free
Naiyer Rizvi, Mark Kris, Vincent Miller, Lee Krug, Sara Bekele, Afshin Dowlati, Kendrith Rowland, Margaret Tonda, Benjamin Mitchell, Jack Ruckdeschel, Ruth Chaplen, Neelesh Aggarwal, Shirish Gadgeel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B124.
Published: 01 November 2007
View article titled, A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations